We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$20.3B
Cap. Flow %
2.85%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.94%
2 Technology 1.9%
3 Communication Services 1.42%
4 Financials 1.08%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNRX icon
12001
PUT
VolitionRx Ltd
VNRX
$4.66M
$103K ﹤0.01%
+1,570
New +$106K
QTEK
12002
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$103K ﹤0.01%
+10,485
New +$103K
TLMD
12003
PUT
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$103K ﹤0.01%
18,100
-7,600
-30% -$50.6K
CENN icon
12004
Cenntro
CENN
$10.2M
$102K ﹤0.01%
18
-19
-51% -$107K
ORN icon
12005
PUT
Orion Group Holdings
ORN
$381M
$102K ﹤0.01%
17,700
-18,300
-51% -$107K
RGLS
12006
DELISTED
Regulus Therapeutics
RGLS
$102K ﹤0.01%
+12,529
New +$140K
DSSI
12007
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$102K ﹤0.01%
+10,218
New +$106K
GNLN icon
12008
CALL
Greenlane Holdings
GNLN
$2.03M
0
MLSS icon
12009
CALL
Milestone Scientific
MLSS
$44.8M
$101K ﹤0.01%
41,100
+18,400
+81% +$44.6K
ORGN
12010
CALL
DELISTED
Origin Materials
ORGN
$101K ﹤0.01%
410
-2,657
-87% -$791K
TKC icon
12011
PUT
Turkcell
TKC
$4.71B
$101K ﹤0.01%
21,600
-24,700
-53% -$116K
BURU.WS
12012
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$101K ﹤0.01%
75,000
AFI
12013
DELISTED
Armstrong Flooring, Inc.
AFI
$101K ﹤0.01%
16,384
-33,190
-67% -$190K
IFRX icon
12014
InflaRx
IFRX
$367M
$100K ﹤0.01%
33,664
-25,807
-43% -$85.6K
MNOV icon
12015
CALL
MediciNova
MNOV
$73.8M
$100K ﹤0.01%
23,500
-18,300
-44% -$78.8K
IIII
12016
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$100K ﹤0.01%
+10,296
New +$101K
TUEM
12017
DELISTED
Tuesday Morning Corp
TUEM
$100K ﹤0.01%
+740
New +$98.9K
GNPX icon
12018
CALL
Genprex
GNPX
$3.28M
$98K ﹤0.01%
1
HOFV
12019
CALL
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$98K ﹤0.01%
+1,136
New +$98.3K
ORN icon
12020
Orion Group Holdings
ORN
$381M
$98K ﹤0.01%
17,002
-21,096
-55% -$123K
RLGT icon
12021
Radiant Logistics
RLGT
$397M
$98K ﹤0.01%
14,076
-15,347
-52% -$111K
WYY icon
12022
CALL
WidePoint Corp
WYY
$94.3M
$98K ﹤0.01%
+13,500
New +$106K
NBSE
12023
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$98K ﹤0.01%
+1,025
New +$113K
FIV
12024
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$98K ﹤0.01%
+10,298
New +$97.2K
JHB
12025
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
$98K ﹤0.01%
10,374
-21,476
-67% -$202K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.